16-methylcyprenorphine has been researched along with morphinans in 12 studies
| Studies (16-methylcyprenorphine) | Trials (16-methylcyprenorphine) | Recent Studies (post-2010) (16-methylcyprenorphine) | Studies (morphinans) | Trials (morphinans) | Recent Studies (post-2010) (morphinans) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 3,251 | 307 | 648 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kane, K; McIntosh, M; Parratt, J | 2 |
| Griffin, IJ; Jackson, HC; Nutt, DJ | 1 |
| Jackson, HC; Nutt, DJ | 1 |
| Freye, E; Schenk, G; Schnitzler, M | 1 |
| Calcagnetti, DJ; Calcagnetti, RL; Fanselow, MS | 1 |
| Dougall, IG; Leff, P | 2 |
| Calcagnetti, DJ; Fanselow, MS; Helmstetter, FJ | 1 |
| Birch, PJ; Hayes, AG; Sheehan, MJ; Tyers, MB | 1 |
| Smith, CF | 1 |
| Birch, PJ; Hayes, AG | 1 |
12 other study(ies) available for 16-methylcyprenorphine and morphinans
| Article | Year |
|---|---|
Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Electrophysiology; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; Hemodynamics; Male; Morphinans; Naltrexone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1992 |
The electrophysiological effects of opioid receptor-selective antagonists on sheep Purkinje fibres.
Topics: Acidosis; Action Potentials; Animals; Coronary Disease; Hyperkalemia; Hypoxia; Morphinans; Naltrexone; Narcotic Antagonists; Purkinje Fibers; Sheep | 1992 |
Endogenous opioids may be involved in idazoxan-induced food intake.
Topics: Adrenergic alpha-Antagonists; Animals; Dioxanes; Dose-Response Relationship, Drug; Eating; Endorphins; Idazoxan; Indoles; Male; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains | 1992 |
Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the rat.
Topics: Analgesia; Animals; Catalepsy; Electroshock; Indoles; Injections, Intraperitoneal; Male; Morphinans; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Receptors, Opioid | 1991 |
Opioid-induced respiratory depression and analgesia may be mediated by different subreceptors.
Topics: Analgesia; Animals; Dogs; Enkephalin, Leucine; Evoked Potentials, Somatosensory; Fentanyl; Morphinans; Narcotics; Receptors, Opioid; Respiration | 1991 |
Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solution.
Topics: Animals; Benzomorphans; Drinking Behavior; Female; Glucose; Injections, Intraventricular; Morphinans; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Saccharin | 1990 |
Estimation of affinities and efficacies for kappa-receptor agonists in guinea-pig ileum.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Binding, Competitive; Cyclazocine; Electric Stimulation; Ethylketocyclazocine; Guinea Pigs; In Vitro Techniques; Male; Models, Biological; Morphinans; Muscle, Smooth; Naltrexone; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa | 1989 |
Delta opioid antagonist, 16-Me cyprenorphine, selectively attenuates conditional fear- and DPDPE-induced analgesia on the formalin test.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Conditioning, Operant; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Fear; Female; Formaldehyde; Injections, Intraventricular; Morphinans; Pain Measurement; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, delta | 1989 |
Estimation of opioid receptor agonist dissociation constants with beta-chlornaltrexamine, an irreversible ligand which also displays agonism.
Topics: Animals; Cyclazocine; Drug Interactions; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Ethylketocyclazocine; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphinans; Muscle, Smooth; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1988 |
In-vivo studies with the opioid antagonist, 16-methylcyprenorphine.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; In Vitro Techniques; Male; Mice; Morphinans; Morphine; Muscle Contraction; Narcotic Antagonists; Pyrrolidines | 1988 |
16-Me cyprenorphine (RX 8008M): a potent opioid antagonist with some delta selectivity.
Topics: Animals; Chemical Phenomena; Chemistry; Guinea Pigs; Ileum; Male; Mice; Morphinans; Rabbits; Rats; Receptors, Opioid; Receptors, Opioid, delta; Vas Deferens | 1987 |
Reversal by beta-funaltrexamine and 16-methyl cyprenorphine of the antinociceptive effects of opioid agonists in the mouse and guinea-pig.
Topics: Abdomen; Animals; Guinea Pigs; Male; Mice; Morphinans; Muscle Contraction; Naltrexone; Narcotic Antagonists; Narcotics; Nociceptors; Pain | 1988 |